117 related articles for article (PubMed ID: 1437231)
1. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka.
Gamage-Mendis AC; Rajakaruna J; Carter R; Mendis KN
Parasite Immunol; 1992 Jul; 14(4):385-96. PubMed ID: 1437231
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
Carter R; David P; Mendis K
Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
[TBL] [Abstract][Full Text] [Related]
4. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.
Mendis C; Del Giudice G; Gamage-Mendis AC; Tougne C; Pessi A; Weerasinghe S; Carter R; Mendis KN
Parasite Immunol; 1992 Jan; 14(1):75-86. PubMed ID: 1557232
[TBL] [Abstract][Full Text] [Related]
5. A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area.
De Zoysa AP; Mendis C; Gamage-Mendis AC; Weerasinghe S; Herath PR; Mendis KN
Bull World Health Organ; 1991; 69(6):725-34. PubMed ID: 1786621
[TBL] [Abstract][Full Text] [Related]
6. Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka.
Gamage-Mendis AC; Rajakaruna J; Carter R; Mendis KN
Am J Trop Med Hyg; 1991 Oct; 45(4):479-87. PubMed ID: 1951856
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka.
Dewasurendra RL; Suriyaphol P; Fernando SD; Carter R; Rockett K; Corran P; Kwiatkowski D; Karunaweera ND;
Malar J; 2012 Aug; 11():281. PubMed ID: 22905743
[TBL] [Abstract][Full Text] [Related]
8. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
9. Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka.
Carter R; Mendis KN
Parassitologia; 1991 Apr; 33(1):67-70. PubMed ID: 1688139
[TBL] [Abstract][Full Text] [Related]
10. Acquired transmission-blocking immunity to Plasmodium vivax in a population of southern coastal Mexico.
Ramsey JM; Salinas E; Rodríguez MH
Am J Trop Med Hyg; 1996 May; 54(5):458-63. PubMed ID: 8644898
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia.
Arévalo-Herrera M; Solarte Y; Zamora F; Mendez F; Yasnot MF; Rocha L; Long C; Miller LH; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):38-43. PubMed ID: 16291765
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
Ramasamy R; Nagendran K; Ramasamy MS
Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
[TBL] [Abstract][Full Text] [Related]
13. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Premaratne PH; Perera KL; Bandara S; Kocken CH; Thomas AW; Handunnetti SM; Udagama-Randeniya PV
Infect Immun; 2006 Jan; 74(1):798-801. PubMed ID: 16369044
[TBL] [Abstract][Full Text] [Related]
14. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon.
Bharti AR; Chuquiyauri R; Brouwer KC; Stancil J; Lin J; Llanos-Cuentas A; Vinetz JM
Am J Trop Med Hyg; 2006 Oct; 75(4):610-6. PubMed ID: 17038681
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.
Arévalo-Herrera M; Solarte Y; Rocha L; Alvarez D; Beier JC; Herrera S
Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):71-7. PubMed ID: 21292881
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease.
Karunaweera ND; Carter R; Grau GE; Mendis KN
Am J Trop Med Hyg; 1998 Feb; 58(2):204-10. PubMed ID: 9502605
[TBL] [Abstract][Full Text] [Related]
18. Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.
Charnaud SC; McGready R; Herten-Crabb A; Powell R; Guy A; Langer C; Richards JS; Gilson PR; Chotivanich K; Tsuboi T; Narum DL; Pimanpanarak M; Simpson JA; Beeson JG; Nosten F; Fowkes FJ
Sci Rep; 2016 Feb; 6():20859. PubMed ID: 26861682
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies.
Mendis C; Gamage-Mendis AC; De Zoysa AP; Abhayawardena TA; Carter R; Herath PR; Mendis KN
Am J Trop Med Hyg; 1990 Apr; 42(4):298-308. PubMed ID: 2184688
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.
Peiris JS; Premawansa S; Ranawaka MB; Udagama PV; Munasinghe YD; Nanayakkara MV; Gamage CP; Carter R; David PH; Mendis KN
Am J Trop Med Hyg; 1988 Jul; 39(1):26-32. PubMed ID: 3041855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
